Literature DB >> 15039445

QO site deficiency can be compensated by extragenic mutations in the hinge region of the iron-sulfur protein in the bc1 complex of Saccharomyces cerevisiae.

Gaël Brasseur1, Danielle Lemesle-Meunier, Floriane Reinaud, Brigitte Meunier.   

Abstract

The mitochondrial bc(1) complex catalyzes the oxidation of ubiquinol and the reduction of cytochrome (cyt) c. The cyt b mutation A144F has been introduced in yeast by the biolistic method. This residue is located in the cyt b cd(1) amphipathic helix in the quinol-oxidizing (Q(O)) site. The resulting mutant was respiration-deficient and was affected in the quinol binding and electron transfer rates at the Q(O) site. An intragenic suppressor mutation was selected (A144F+F179L) that partially alleviated the defect of quinol oxidation of the original mutant A144F. The suppressor mutation F179L, located at less than 4 A from A144F, is likely to compensate directly the steric hindrance caused by phenylalanine at position 144. A second set of suppressor mutations was obtained, which also partially restored the quinol oxidation activity of the bc(1) complex. They were located about 20 A from A144F in the hinge region of the iron-sulfur protein (ISP) between residues 85 and 92. This flexible region is crucial for the movement of the ISP between cyt b and cyt c(1) during enzyme turnover. Our results suggested that the compensatory effect of the mutations in ISP was due to the repositioning of this subunit on cyt b during quinol oxidation. This genetic and biochemical study thus revealed the close interaction between the cyt b cd(1) helix in the quinol-oxidizing Q(O) site and the ISP via the flexible hinge region and that fine-tuning of the Q(O) site catalysis can be achieved by subtle changes in the linker domain of the ISP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039445     DOI: 10.1074/jbc.M311576200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.

Authors:  Zehua Song; Jérôme Clain; Bogdan I Iorga; Zhou Yi; Nicholas Fisher; Brigitte Meunier
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

2.  Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.

Authors:  Nicholas Fisher; Roslaini Abd Majid; Thomas Antoine; Mohammed Al-Helal; Ashley J Warman; David J Johnson; Alexandre S Lawrenson; Hilary Ranson; Paul M O'Neill; Stephen A Ward; Giancarlo A Biagini
Journal:  J Biol Chem       Date:  2012-01-26       Impact factor: 5.157

3.  3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents.

Authors:  Hanine Hadni; Menana Elhallaoui
Journal:  Heliyon       Date:  2020-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.